Review question/objective The objective of this review is to determine the best available evidence related to the effect of insulin therapy algorithms on blood glucose levels in patients in critical care environments following cardiac surgery. More specifically, the review question to be answered is: Among adults within critical care environments who are in the acute postoperative phase (5 days) following cardiac surgery, what is the effect of insulin therapy algorithms for the control of blood glucose levels?
Review question/objective
The objective of this review is to determine the best available evidence related to the effect of insulin therapy algorithms on blood glucose levels in patients in critical care environments following cardiac surgery.
More specifically, the review question to be answered is:
Among adults within critical care environments who are in the acute postoperative phase (5 days) following cardiac surgery, what is the effect of insulin therapy algorithms for the control of blood glucose levels?
Background
Hyperglycemia, a condition characterized by elevated blood glucose levels (BGLs), is most commonly associated with diabetic illness. 1 However, hyperglycemia has also been found to have a high incidence after cardiac surgery. Current literature surrounding this topic suggests that hyperglycemia occurs almost universally after cardiac surgery; irrespective of whether a person has a pre-existing diagnosis of diabetes mellitus or not. [1] [2] [3] Conventionally, post-operative hyperglycemia following cardiac surgery was viewed purely as a natural adaptive physiological response of the body that was treated only when
BGLs rose to what was considered excessively high levels; 2 generally greater than 12.2 mmol/L [220mg/dl]. 4 This view has since changed and hyperglycemia following cardiac surgery is now viewed as an adverse effect of surgery, occurring as a result of multiple factors that include: the intraoperative hypothermic state, surgical stress, hypokalemia, adverse effects from pharmacological agents and the commonly occurring post-operative systemic inflammatory response. [5] [6] [7] While generally only transient, an incidence of hyperglycemia during the initial post-operative period can have serious detrimental side effects following cardiac surgery such as deep sternal wound infection and an increased risk of mortality. 8 Current evidence suggests that within critical care environments, the early recognition and treatment of post-operative hyperglycemia is imperative. This is achieved through the utilization of continuous intravenous insulin infusion algorithms, with the aim of maintaining BGLs within normal to near normal ranges, in order to prevent the adverse outcomes associated with hyperglycemia in post-operative patients. 9 The practice of maintaining BGLs within strict pre-defined levels, via the administration and titration of a continuous insulin infusion, has become common practice within critical care environments over the past decade. 10 Results from a study by Van A review of the literature shows that a number of insulin infusion algorithms, with varying methods and effects, have been developed for utilization by clinicians in critical care environments to guide the management of hyperglycemia. Due to the conflicting evidence that currently exists, the critical care
clinician responsible for the provision of care to post-operative cardiac surgery patients needs to determine the best evidence in relation to the management of hyperglycemia, to maintain patient safety and ensure good surgical outcomes, free from complications. However, a review of the outcomes of these protocols for cardiac patients has not been published to inform the development of best evidence based practice guidelines. This systematic review therefore aims to review the various protocols to ascertain the best available evidence related to the effect of intensive insulin therapy algorithms on BGLs in post-operative patients in critical care environments following cardiac surgery.
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Inclusion criteria

Types of participants
This review will consider studies that include adult patients aged 18 years and over admitted to a critical care unit following cardiac surgery and who received insulin therapy for glycemic control during the acute postoperative phase (five days) of admission.
In this review studies that include participants with a known diagnosis of Diabetic Ketoacidosis will be excluded.
Types of intervention(s)/phenomena of interest
This review will consider studies that evaluate the use of intravenous insulin therapy algorithms to control blood glucose levels in acute postoperative phase patients in critical care environments following cardiac surgery.
In this review, studies will be included if they make one of the following comparisons:
1. Intravenous insulin therapy algorithm compared to another insulin therapy algorithm.
2. Intravenous insulin therapy algorithm compared to no treatment.
Intravenous insulin therapy algorithm compared to a placebo.
In this review, studies that include a Glucose-Insulin-Potassium (GIK) infusion as an intervention or a comparator will be excluded.
Types of outcomes
This review will consider studies that include the following outcome measures:
Primary outcome:
 Overall control of blood glucose levels as measured by time to target BGL range, time spent in BGL target range and time above or below target BGL range.
Secondary outcome:
 Incidence of adverse events, including:
-Hypo/hyper glycemia, measured by standard point of care glucometers, arterial blood analysis, or venous blood analysis, with hypoglycemia defined as a BGL reading <3.9mmol/L (70mg/dL) 13 and hyperglycemia defined as a BGL reading >7.8mmol/L(140mg/dL). 
Types of studies
This review will consider any experimental study design including randomized controlled trials, non-randomized controlled trials, quasi-experimental and before and after studies for inclusion.
Search strategy
The search strategy aims to find both published and unpublished studies. A three-step search strategy will be utilized in this review. An initial limited search of MEDLINE and CINAHL will be undertaken, followed by analysis of the text words contained in the title and abstract and of the index terms used to describe the article. A second search using all identified keywords and index terms will then be undertaken across all included databases. Thirdly, the reference lists of all identified reports and articles will be hand searched for additional studies.
Studies published in the English language will be considered for inclusion in this review. Databases will be searched with no limits placed on the date of publication, allowing authors to search as far back as possible.
The databases to be searched include:
MEDLINE, CINAHL, PubMed, Embase, SCOPUS, Cochrane Trials, Dare, Social Science Index.
The search for unpublished studies will include: 
Assessment of methodological quality
Papers selected for retrieval will be assessed by two independent reviewers for methodological validity prior to inclusion in the review using standardized critical appraisal instruments from the Joanna Briggs
Institute Meta-Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) (Appendix I).
Any disagreements that arise between the reviewers will be resolved through discussion, or with a third reviewer.
Data collection
Data will be extracted from papers included in the review using the standardized data extraction tool from JBI-MAStARI (Appendix II). The data extracted will include specific details about the interventions, populations, study methods and outcomes of significance to the review question and specific objectives.
Data synthesis
Quantitative data will, where possible, be pooled in statistical meta-analysis using JBI-MAStARI. All results will be subject to double data entry. Effect sizes expressed as odds ratios (for categorical data) and weighted mean differences (for continuous data) and their 95% confidence intervals will be calculated for analysis. Heterogeneity will be assessed statistically using the standard Chi-square and also explored using subgroup analyses based on the different study designs included in this review.
Where statistical pooling is not possible, the findings will be presented in narrative form including tables and figures to aid in data presentation where appropriate.
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